Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters-Reference-Cited by-同舟云学术

Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters

Published:2019-11 Issue:47 Volume:98 Page:e18067
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Abe Ichiro,Ochi Kentaro,Takashi Yuichi,Yamao Yuka,Ohishi Hanako,Fujii Hideyuki,Minezaki Midori,Sugimoto Kaoru,Kudo Tadachika,Abe Makiko,Ohnishi Yasushi,Mukoubara Shigeaki,Kobayashi Kunihisa

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference22 articles.

1. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives;Virally;Diabetes Metab,2007

2. Global and societal implications of the diabetes epidemic;Zimmet;Nature,2001

3. Importance of glucose control;Edelman;Med Clin North Am,1998

4. Type 2 diabetes mellitus and fracture risk;Dede;Metabolism,2014

5. Fracture risk in type 2 diabetes: update of a population-based study;Melton;J Bone Miner Res,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of denosumab in osteoporosis – an update on efficacy and drug safety;Expert Opinion on Drug Safety;2024-09-11

2. Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study;Osteoporosis International;2024-07-24

3. Energy homeostasis in the bone;Trends in Endocrinology & Metabolism;2024-05

4. Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT;The Journal of Clinical Endocrinology & Metabolism;2024-01-05

5. Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial;Trials;2023-12-18